VBI Vaccines Entered Into A Binding Dip Facility Term Sheet With K2 HealthVentures; Pursuant To Binding Term Sheet, K2HV Has Agreed To Make Up To $2.5M Available To Co And Its Units
Portfolio Pulse from Benzinga Newsdesk
VBI Vaccines has entered into a binding DIP facility term sheet with K2 HealthVentures, which will make up to $2.5 million available to the company and its units.
July 30, 2024 | 2:32 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
VBI Vaccines has secured up to $2.5 million in funding from K2 HealthVentures through a binding DIP facility term sheet. This funding will provide financial support to the company and its units.
The secured funding of up to $2.5 million will provide VBI Vaccines with necessary financial support, potentially stabilizing its operations and improving investor confidence in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100